CMOTEC-B.ST

Scandinavian ChemoTech AB (publ) [CMOTEC-B.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

CMOTEC-B.ST Stock Summary

In the News

CMOTEC-B.ST Financial details

Company Rating
-
Market Cap
41.79M
Income
-21.2M
Revenue
2.82M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
6
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
-1.44
Forward P/E
-
PEG
0.4
P/S
17.74
P/B
4.82
P/C
-
P/FCF
-2.25
Quick Ratio
0.11
Current Ratio
0.87
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.59
EPS next Y
-
EPS next Q
-
EPS this Y
-36.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-12.61%
Revenue last 5Y
38.39%
Revenue Q/Q
-53.06%
EPS Q/Q
6.06%
-
-
-
-
SMA20
-
SMA50
-20%
SMA100
33.33%
Inst Own
-
Inst Trans
-
ROA
-136%
ROE
-216%
ROC
-3.03%
Gross Margin
79%
Oper. Margin
-821%
Profit Margin
-911%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.635-5.94
52W High
-17%
52W Low
+315%
RSI
46
Rel Volume
0.69
Avg Volume
33.94K
Volume
23.4K
Perf Week
-9.98%
Perf Month
14.33%
Perf Quarter
97.62%
Perf Half Y
107.5%
-
-
-
-
Beta
1.407
-
-
Volatility
0.11%, 0.51%
Prev Close
-0.24%
Price
4.15
Change
0.24%

Something similar

Top by Market Cap
DHR-PB
NVDA
LLY.DE
M&M.NS
AAPL
Same Sector
PPD
DBVT
0858.HK
SLGC
AEZS
Same Price Range
600227.SS
EWCZ
USAS
DIV.TO
IR5B.IR
Similar Market Cap
DPDEX
18M3.DE
ALOSM.PA
ROCG
STCB

Company Profile

Healthcare Biotechnology
  • Volume Average 33.94K
  • Market Capitalization 41.79M
  • Employee 6
  • CEO Mr. Stefan Mohan Frick
  • Headquarters Lund,SE
  • IPO Date 2016-12-06
  • Website https://chemotech.se

Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.